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Fatigue is one of the most disabling side effects in people with multiple sclerosis. While 
this fact is well known, there has been a remarkable lack of progress in determining 
the pathophysiological mechanisms behind fatigue and the establishment of effective 
treatments. The main barrier has been the lack of a unified definition of fatigue that can 
be objectively tested with validated experimental models. In this “perspective article” 
we propose the use of the following model and definition of fatigue: the decrease in 
physical and/or mental performance that results from changes in central, psychological, 
and/or peripheral factors. These changes depend on the task being performed, the 
environmental conditions it is performed in, and the physical and mental capacity of 
the individual. Our definition and model of fatigue outlines specific causes of fatigue 
and how it affects task performance. We also outline the strengths and weaknesses of 
commonly used measures of fatigue and suggest, based on our model and definition, 
new research strategies, which should include multiple measures. These studies should 
be mechanistic with validated experimental models to determine changes in central, 
psychological, and/or peripheral factors that explain fatigue. The proposed new research 
strategies may lead to the identification of the origins of MS related fatigue and the 
development of new, more effective treatments.
Keywords: multiple sclerosis, perceptions, performance fatigability, neuroimaging, questionnaires
Fatigue is the most common and disabling symptom experience by people with multiple sclerosis 
(PwMS). Up to 92% of PwMS are affected by fatigue, which strongly influences quality of life (1). 
However, fatigue remains poorly understood and PwMS continue to suffer from a lack of effective 
fatigue treatments. Despite significant effort to elucidate the pathogenic mechanisms of fatigue, cur-
rent knowledge is limited. Several factors contribute to the lack of progress in fatigue research, but 
the most important factor is that “fatigue” is often not clearly defined or is used without meaningful 
measurements in clinical and research settings (2). Kluger et al. (3) states: “Current treatments are 
non-specifically targeted to a vaguely defined symptom with unsatisfactory outcomes.” Providing 
further support to these statements, a recent Cochrane Review (4) on exercise therapy for fatigue 
in MS concluded there are important methodological issues to overcome. Heine et al. (4) reported 
most studies did not: explicitly include PwMS who experienced fatigue, use a validated measure 
of fatigue as the primary outcome, or target fatigue specifically. Berger (5) questions whether MS 
related fatigue can be treated and improved with current disease-modifying drugs, e.g., amantadine, 
methylphenidate, and modafinil, without having a precise definition of fatigue.
In this “perspective paper” we propose a model of fatigue designed to give clinicians and research-
ers a better understanding of fatigue, critically review current fatigue measures used in MS, and 
FiGUre 1 | Fatigue is defined as the decrease in physical and/or mental performance that results from changes in central, psychological, and/or 
peripheral factors. These depend on the task being performed, the environmental conditions it is performed in, and the physical and mental capacity of the 
individual (conditional dependency). Importantly, fatigue is greatly affected by the factors of conditional dependency and the interactive changes in central, 
psychological, and/or peripheral factors that cause fatigue.
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provide suggestions for new research strategies to better under-
stand fatigue in MS.
DeFiNitiONs OF FAtiGUe
Many studies investigating fatigue have failed to objectively 
define fatigue, and those that did, have used varying definitions. 
Furthermore, the origins of fatigue vary between conditions and 
research in some diseases, such as MS, has failed to fully under-
stand the difference between fatigue and related phenomena, such 
as depressed mood or sleep disorders (3). As a result, Kluger and 
colleagues (3) recently proposed a unified taxonomy for fatigue 
in neurological disorders that classified fatigue into two major 
domains: performance fatigability and perceptions of fatigue. 
Performance fatigability was defined as the magnitude or rate of 
change in a performance criterion relative to a reference value 
over a given time of task performance. Perceptions of fatigue was 
defined as a subjective sensation of weariness, increasing sense 
of effort, mismatch between effort expended and actual perfor-
mance, or exhaustion.
We propose fatigue should be defined as: the decrease 
in physical and/or mental performance that results from 
changes in central, psychological, and/or peripheral factors. 
Indeed these factors all have conditional dependency in that 
the changes in central, psychological, and peripheral factors 
of fatigue depend on the task being performed, the environ-
mental conditions it is performed in, and the physical and 
mental capacity of the individual (Figure 1). Central factors 
of fatigue are related to changes within the function of the 
central nervous system, such as neurotransmitter levels and 
intrinsic neuronal excitability, while psychological factors of 
fatigue include mood disorders, perceptions of effort, motiva-
tion, temporal and performance feedback, and arousal. Finally, 
peripheral factors of fatigue refer to physiological changes, 
such as pH, muscle contractility and excitability, and substrate 
availability. Importantly, the phrase factors of fatigue is used 
because there are many changes from a variety of locations that 
can all interact to contribute to fatigue. As a result, terminology 
that refers to a specific location of the fatigue, such as central, 
peripheral, and muscle, should be avoided as fatigue is almost 
never focused to a specific location.
Task dependency has been identified and discussed as a 
component of fatigue in healthy individuals for several decades 
(6–9). A variety of human studies indicate that fatigue is not 
caused exclusively by any common set of factors, but depends 
on the type of cognitive or motor task that is being performed. 
However, many conditions beyond the specific task being per-
formed can affect fatigue. One distinct difference between our 
model and previous models (3, 10) is the concept of conditional 
dependency, which considers not only task dependency but also 
how the condition it is performed in and the physical and mental 
capacity of the individual affect fatigue. Environmental depend-
ency considers how factors of the environment affect fatigue, such 
as temperature and comfort level of the individual in the space. 
This can be of particular importance in MS, as warm environ-
ments can greatly affect physical abilities of PwMS (11). Finally, 
fatigue depends on a person’s physical and mental capacity, which 
includes the consideration of differences in fatigue before and 
after the onset of a disease or day-to-day variation in disease status 
due to disease progression or temporary relapse. These different 
conditions each interact with each other, as well as the central, 
psychological, and peripheral factors of fatigue discussed above. 
Our model not only displays how the varying conditions affect 
the interactive/factors but also the importance of considering the 
impact of factors, such as depression, general lack of motivation, 
and altered states of arousal, when measuring fatigue. This is most 
easily seen in the reported interactions between depression and 
fatigue in PwMS, where studies have shown that reported fatigue 
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levels often decrease once depression is accounted for (12, 13). 
Therefore, what is being reported as “fatigue” is often a manifesta-
tion of an underlying condition, which may or may not be related 
to an individual’s ability to perform a task.
AssessMeNt OF FAtiGUe iN Ms
The two interactive subtypes (perception and performance) of 
fatigue proposed by Kluger and colleagues (3) are each important 
when considering the impact of fatigue on PwMS. Increased 
perceptions of fatigue can have a significant impact on activities 
of daily living, mood, and likelihood to engage in social activities, 
resulting in a reduced quality of life. While performance fatigabil-
ity may only impact PwMS during a task, it has meaningful impact 
on an individual’s ability to perform activities of daily living and 
to live independently. Furthermore, performance fatigability 
impacts an individual’s exercise capacity, which is important in 
managing the symptoms of MS (14).
subjective Measurements of Fatigue
A remarkable number of questionnaires have been developed to 
assess fatigue. They range in length from single-item scales [e.g., 
visual analog scale (VAS)], to multidimensional scales claiming to 
assess various dimensions of fatigue, such as physical vs. mental 
[e.g., modified fatigue impact scale (MFIS)]. Most of the items 
on these assessments are similar and correlate very well with 
each other. One major issue with fatigue questionnaires is the 
construct contamination that mars the validity and specificity of 
such scales (2). For example, fatigue questionnaires often include 
questions about tiredness and cognition, which are not always 
associated with fatigue (2).
Self-report questionnaires can be influenced by other 
symptoms of MS, require patients to make difficult reflective 
assessments, and are completely subjective. Despite these limita-
tions, the fatigue severity scale (FSS) (15) and the MFIS (16) are 
commonly the only measures of fatigue in many studies [e.g., Ref. 
(17–19)]. Most of these studies were incapable of demonstrating 
responsiveness to changes over time to therapeutic interventions, 
likely because of a lack of specificity in the questions or underly-
ing factors of MS that may be reported as fatigue. However, 
questionnaires will continue to have value, especially for measur-
ing perceptions of fatigue, until quick and easy objective clinical 
assessments are available.
Objective Measurements of Fatigue
Objective measures of fatigue are limited to variables obtained 
during physical or mental tasks, and measured pre-, during-, and 
post-task. The measures of these tasks can be objectively quanti-
fied in research and clinical settings. Fatigue during motor tasks is 
usually characterized by the decline in peak force, power, accuracy, 
or speed from pre- to post-task. During cognitive tasks, fatigue 
is often measured as declines in reaction time or accuracy-over-
time on continuous tasks. While several studies have attempted 
to objectively quantify MS related factors of fatigue using the 
neuroimaging techniques (described below), they have failed to 
measure factors of performance fatigability. Separating fatigue 
into the motor and cognitive tasks or domains provides objective 
assessments that are less likely to be contaminated by other symp-
toms of MS and help distinguish fatigue from related factors, such 
as reduced cognitive processing speed, sleep disorders, depressive 
symptoms, and anxiety (20, 21). Therefore, it is suggested that 
measures, such as sleepiness and mood be included as covariates, 
when investigating MS related fatigue. Depression, mood, anxi-
ety, cognitive–behavioral factors, motivation, sleep disorders, and 
low sense of control contribute to fatigue (22–24). How people 
then react to these underlying conditions may serve to prolong or 
worsen fatigue. Specifically, depression affects a significant pro-
portion of PwMS during their life span (25). Accordingly, Bakshi 
et  al. (26) found that depression is associated with MS related 
fatigue, indicating that depression should be controlled for.
Once fatigue is defined, valid tasks and indices may be 
employed to measure the contributing factors of fatigue. Several 
technologies are available to investigate the changes in these 
factors during tasks, including: electromyography, metabolic 
measures, transcranial magnetic stimulation, magnetic reso-
nance imaging (MRI), near infrared spectroscopy, and positron 
emission tomography (PET). Since MS related fatigue is a mul-
tifactorial problem, it is important to use multiple instruments 
to investigate fatigue, and identify the central, psychological, 
and peripheral factors contributing to the decrease in task 
performance.
FActOrs cONtriBUtiNG tO  
FAtiGUe iN Ms
central Factors
Central factors contributing to fatigue include neurotransmitter 
levels, inflammation, neuronal excitability, substrate utilization/
transport, axonal conduction velocity, and many others. CNS 
inflammation is a hallmark of MS and has been suggested to 
play a role in MS related fatigue, although the current literature 
reports conflicting findings (27). For example, some researchers 
have shown associations between cytokine levels and fatigue 
questionnaire scores (28–30), while others have shown no asso-
ciation between cytokine or c-reactive protein levels with fatigue 
questionnaires (31, 32). Therefore, future research is needed to 
determine whether CNS inflammation, in addition to many other 
factors, is a potential central factor of fatigue in MS.
Neuroimaging studies have started to provide direct evidence 
of the central factors of fatigue in MS. Roelcke et al. (33) used 
18F-fluorodeoxyglucose-PET to measure cerebral glucose 
metabolism in PwMS. They found significant hypometabolism 
throughout the brain in fatigued PwMS, based on FSS scores, 
suggesting dysfunctional cerebral activity might be responsible in 
MS related fatigue. However, it cannot be ruled out that cerebral 
hypometabolism is caused by other symptoms, such as depres-
sion, which were not specified in the fatigue questionnaire.
Functional-magnetic resonance imaging (fMRI) is a promi-
nent neuroimaging technique used to investigate cerebral 
activity. Although this technique provides the opportunity to 
detect brain regions involved with motor or cognitive tasks, the 
interpretations and conclusions resulting from fMRI studies 
are often misleading. A good example is a recent fMRI study 
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that examined cognitive fatigue in PwMS (34). A cognitive task 
was performed within the MRI scanner and the VAS was used 
during the task to measure “state” cognitive fatigue (35). The 
authors concluded that PwMS had increased brain activity in 
the caudate, compared to healthy controls, resulting in greater 
VAS scores. However, there was no significant group x time 
interaction, indicating the task elicited the same change in 
task performance (fatigue) in both the MS and healthy groups. 
Furthermore, performances on the neurophysiological tests 
were not different between groups. Similar findings were seen 
in Rocca et  al. (36), where fMRI during a motor task was 
obtained from PwMS with and without “fatigue” and matched 
healthy controls. Brain activation strategies were different 
between the groups during the motor tasks without differ-
ences or changes in task performance. Task performance was 
similar between the investigated groups in both studies, which 
suggests that the findings only help explain underlying factors 
that contributed to the initial difference in fatigue between the 
groups (perceptions of fatigue), not performance fatigability. 
If altered brain activation strategies lead to decreased task 
performance, then conclusions about performance fatigability 
could have been made.
It has been suggested that an imbalance of dopamine in the 
CNS and immune system plays an important role in fatigue 
(37). Neuroimaging studies have shown that brain regions with 
impaired structure and function are heavily innervated by dopa-
minergic neurons (38, 39). Rönnbäck and Hansson (40) stated 
that “mental fatigue” is also associated with impaired glutamate 
neurotransmission and hypothesized that there might be a 
genetic failure preventing astroglial glutamate transporters from 
upregulating. In our model, the aforementioned findings refer to 
perceptions which are modulated by central and psychological 
factors, and if they do not change during the performance of a 
task they should only be classified as a factor of perceptions of 
fatigue.
Some studies showed associations between fatigue and lesion 
load/location and the degree of gray matter atrophy (41, 42). 
They found that MS related fatigue, assessed by the MFIS, FSS, 
and MRI, is at least partially associated with disruption of frontal 
and parietal pathways and cortical areas involved in cognitive/
attentional processing. However, based on our proposed model 
of fatigue, it remains unknown whether structural brain changes, 
such as atrophy and lesion load, are factors of performance 
fatigability since they have not been associated with an objective 
measure of performance fatigue.
Together, these studies show that central factors of fatigue 
undoubtedly contribute to perceptions of fatigue in PwMS. 
However, the necessary measures of performance fatigability 
have not been performed in these studies, and therefore it is still 
unknown whether these central factors contribute to performance 
fatigability in PwMS.
Psychological Factors
Psychological factors, such as perceived effort, subjective sense 
of worsening performance over time, motivation, and cognitive 
impairment are contributors to fatigue (43). Serotonin (44) 
and dopamine (45) are just two examples of central factors that 
influence psychological factors and play an important role in 
fatigue. Engström et al. (46) showed that PwMS who have high 
fatigue demonstrate reduced mesocorticolimbic connectivity 
compared to healthy adults during a complex working memory 
task. Finke et al. (47) showed that high fatigue scores in PwMS 
were negatively correlated with resting-state mesocorticolimbic 
connectivity. These findings suggest that MS related fatigue is 
associated with reduced connectivity between the regions inner-
vated with dopamine, possibly due to reduced dopamine levels.
Peripheral Factors
Fatigue in PwMS can also arise from one or several of the peripheral 
factors that were described above. Slowing of muscle contractile 
properties (48–51), decreased muscle oxidative capacity (48, 52), 
impaired excitation–contraction coupling (50, 53), and altered 
muscle metabolic response to exercise (50, 53, 54) may contribute 
to fatigue in MS. Sharma et al. (50) showed that intramuscular 
components contribute to fatigue in MS by demonstrating that 
greater decreases in phosphocreatine and intracellular pH was 
associated with greater force reduction (performance fatigabil-
ity). In this context, it is important to mention muscle afferent 
feedback, which includes the possibility that metabolites can alter 
CNS motor output (55).
FiNAL tHOUGHts AND FUtUre 
reseArcH DirectiONs
When compared to advances made in other domains of disease 
status and disability in PwMS, fatigue continues to lag behind. 
The lack of progress is largely due to the varying subjectivity in 
the definition and assessment of fatigue between research groups. 
Our proposed theoretical model provides specific areas of objec-
tive fatigue assessment that can be applied in research and inter-
vention settings. Because of the complexity of fatigue in PwMS, 
it is important that future studies should not only account for 
covariates, including depression and sleepiness, but also require 
integration of multiple measures directed at the different factors 
that influence fatigue. Currently, several techniques are available 
to measure many of the factors that could contribute to fatigue 
in PwMS. Central factors can be examined via neuroimaging 
techniques, such as PET and MRI, psychological factors via the 
Brief Repeatable Battery of Neuropsychological Tests (56), and 
peripheral factors with electromyography and MR spectroscopy 
to name a few.
In this “perspective paper” we proposed a standardized defini-
tion of fatigue and identified factors that contribute to fatigue. 
However, this list is not exhaustive; our model is hypothetical and 
further research is needed to elucidate all mechanisms of MS 
related fatigue and to validate our proposed model. Research 
studies should focus on clearly defined outcome variables, which 
contribute to fatigue and not primarily on the location of fatigue. 
Future research studies on MS related fatigue should be extended 
to include psychological screening to determine underlying 
conditions, which may or may not impair task performance 
but should be distinguished from fatigue. We propose fatigue 
should be defined as: the decrease in physical and/or mental 
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performance that results from changes in central, psychological, 
and/or peripheral factors. Importantly, these changes depend 
on the task being performed, the environmental conditions it is 
performed in, and the disease status of the individual.
An example for the objective measurement of fatigue in PwMS 
with defined outcome variables is a study by Sharma et al. (50). 
Fatigability of the anterior tibialis muscle was quantified in PwMS 
and controls during intermittent electrical stimulation. During 
stimulation, the decline in tetanic force, phosphocreatine, and 
intracellular pH was greater in PwMS than in controls, indicat-
ing an abnormal intramuscular component of fatigue in MS. 
Importantly, this study eliminated the influence of perceptions of 
fatigue since it did not involve voluntary muscle activity.
While the study design described above was ideal to identify 
several peripheral factors of performance fatigability, future stud-
ies must include voluntary muscle activity, which incorporates 
central and psychological factors, to fully understand fatigue. 
This can be accomplished by measuring changes in peripheral 
factors (muscle strength and activity, pH, glycogen, etc.), as well 
as measures of central and psychological factors (dopamine, 
motivation, perceived effort, etc.). For example, the design used by 
Sharma et al. (50) could be expanded to include voluntary muscle 
activity, and neuroimaging techniques (fMRI and PET) could be 
applied to measure changes in central and psychological factors. 
Perceptions of fatigue should be monitored in this example using 
the techniques, such as the Borg scale of perceived exertion. The 
associations of these measures then may provide insights to the 
origins and mechanisms of MS related fatigue.
By using a uniformed understanding and measurement of 
fatigue, progress may finally be made in effectively treating the 
symptoms of fatigue and improving quality of life in PwMS.
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